INS and Hypoglycemia: Although hProC(A7)Y-CpepGFP transgenic mice did not gain weight during the therapy (Figure 2B) and did not develop hypoglycemia after therapy withdrawal (not shown), plasma C-peptide level almost doubled 2 days after insulin therapy withdrawal (Figure 2D).